618OHealth-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR). (18th September 2017) - Vogel, A.; Qin, S.; Kudo, M.; Hudgens, S.; Yamashita, T.; Yoon, J-H.; Fartoux, L.; Simon, K.; López López, C.; Sung, M.; Dutcus, C.; Kraljevic, S.; et al.